Roberts Carly L, Farrell Lara J, Waters Allison M, Oar Ella L, Ollendick Thomas H
School of Applied Psychology and Menzies Health Institute QLD, Griffith University, Gold Coast Campus, Southport, QLD, 4222, Australia.
School of Applied Psychology and Menzies Health Institute, Griffith University, Mount Gravatt Campus, Mount Gravatt, QLD, 4122, Australia.
Child Psychiatry Hum Dev. 2016 Jun;47(3):459-71. doi: 10.1007/s10578-015-0579-2.
This study aimed to examine parents' perceptions of established treatments, including cognitive behaviour therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs), relative to novel treatments of D-cycloserine (DCS) and attention bias modification (ABM) augmented CBT to determine if novel treatments are perceived as more or less favorable than established treatments. Participants included parents of children with a specific phobia, enrolled in one of two randomized controlled trials of either one-session augmented DCS (n = 38, Gold Coast) or ABM augmented one-session treatment (n = 34, Brisbane), as well as parents from a community sample (n = 38). Parents of children with a specific phobia perceived CBT most favorably. There was no difference between the sites on perceptions of ABM. However, parents of children enrolled in the DCS trial perceived DCS more favorably than parents of children enrolled in the ABM trial and the community sample. These results demonstrate parents' greater acceptance of psychological treatments over pharmacological treatments for the treatment of childhood phobias, highlighting the importance of educating parents to novel treatments.
本研究旨在考察家长对已确立的治疗方法（包括认知行为疗法（CBT）和选择性5-羟色胺再摄取抑制剂（SSRIs））的看法，相对于新型治疗方法D-环丝氨酸（DCS）和注意力偏差修正（ABM）增强的CBT，以确定新型治疗方法是否被认为比已确立的治疗方法更有利或更不利。参与者包括患有特定恐惧症儿童的家长，他们参与了两项随机对照试验之一，一项是单疗程增强DCS试验（n = 38，黄金海岸），另一项是ABM增强单疗程治疗试验（n = 34，布里斯班），以及来自社区样本的家长（n = 38）。患有特定恐惧症儿童的家长对CBT的评价最为有利。各研究点对ABM的看法没有差异。然而——参与DCS试验的儿童的家长比参与ABM试验的儿童的家长和社区样本的家长对DCS的评价更有利。这些结果表明，家长对治疗儿童恐惧症的心理治疗方法的接受程度高于药物治疗方法，突出了对家长进行新型治疗方法教育的重要性。
Zotero 插件